載入...
Treatment rationale and design of the RAMNITA study: A phase II study of the efficacy of docetaxel + ramucirumab for non–small cell lung cancer with brain metastasis
BACKGROUND: We described the treatment rationale and procedure for a phase II study of docetaxel plus ramucirumab for non–small cell lung cancer (NSCLC) patients with brain metastasis (RAMNITA study: University Information Network Clinical Trials Registry identification no. [UMIN]: 000024551). Combi...
Na minha lista:
| 發表在: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wolters Kluwer Health
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5999517/ https://ncbi.nlm.nih.gov/pubmed/29879079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011084 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|